Italia markets closed

Pharvaris N.V. (9EN.SG)

Stuttgart - Stuttgart Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
20,40-0,40 (-1,92%)
In data: 03:39PM CEST. Mercato aperto.
Schermo intero
Chiusura precedente20,80
Aperto20,80
Denaro19,50 x N/D
Lettera21,00 x N/D
Min-Max giorno20,40 - 20,80
Intervallo di 52 settimane20,40 - 20,80
Volume0
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)N/D
Rapporto PE (ttm)N/D
EPS (ttm)N/D
Prossima data utiliN/D
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Pharvaris To Present at the APAAACI 2023 International Conference

    ZUG, Switzerland, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced the acceptance of an abstract oral presentation at the Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI) and Allergy and Clinical Immunology Society of Singapore (ACIS) APAAACI 2023 International Conference, to be held from October 23-2

  • GlobeNewswire

    Pharvaris To Present at the CIIC Fall 2023 Conference

    ZUG, Switzerland, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced the acceptance of two abstracts for ePoster presentation at the Consortium of Independent Immunology Clinics (CIIC) Fall 2023 Conference, to be held from October 13-14, 2023, at the Gaylord Texan Resort in Dallas, TX. Presentation details: Title: Efficacy and safet

  • GlobeNewswire

    Pharvaris To Participate in the 2023 Cantor Global Healthcare Conference

    ZUG, Switzerland, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, will attend the 2023 Cantor Global Healthcare Conference, taking place in New York from September 26-28, 2023. Pharvaris management will participate in a fireside chat on Tuesday, September 26, from 2:10-2:40 p.m. ET. A live audio webcast of the 2023 Cantor Global Healthcare Conf